Shelf life is one of the few line items on a Gulf skincare purchase order that can stop a container at customs, trigger a retailer rejection, or quietly destroy margin after the goods are already in a Dubai or Riyadh warehouse. Importers in Saudi Arabia and the UAE are usually asked for a production date, an expiry date, and a period-after-opening (PAO) value — but those numbers only mean something if the manufacturer can show the long-term stability, microbiological, and packaging-compatibility evidence behind them. This guide is written for sourcing managers and brand owners who need to check that evidence chain before they place an order, not after. Informational only, not legal advice.
TL;DR — what Gulf buyers should lock in 60 seconds
- What triggers the risk: entering Saudi Arabia (SFDA/GSO framework) or the UAE (MoIAT or Emirate/Municipality path) means a local importer or notifier, market-specific labeling language, dates/PAO, SDS for the actual shipping version, and customs documentation — while sea freight and unairconditioned warehousing expose the product to heat and humidity far beyond a stability chamber.
- Decide these three things first: (1) the exact country and route, not “the Middle East”; (2) the locked formula version and locked pack; (3) the basis on which you will print shelf life and PAO.
- Fastest safe path: lock packaging and specification, start long-term stability on a pilot batch, run preservative efficacy and micro in parallel, and send the label pack for market review early. Accelerated data is a screening tool — it is not a shelf-life multiplier.
- Optimize later: artwork polish, secondary packaging, carton design, marketing claims.
- Request these five items immediately: long-term stability protocol plus raw data at defined timepoints; preservative efficacy test (PET) and micro specification; packaging compatibility and seal/pump function report; final label artwork with INCI, batch, expiry, PAO and fragrance allergens; COA and SDS matching the shipping version.
Informational only, not legal advice.
Decision tree — classify your situation before you request a quote
- Start here: Is the product an ordinary cosmetic in your target Gulf country, with no treatment or structure/function claim?
- If yes, and market = Saudi Arabia: confirm local importer/notifier, applicable SFDA/GSO requirements, Arabic or bilingual labeling, INCI, dates/PAO, SDS/dangerous-goods documents and import clearance paperwork.
- If yes, and market = UAE: confirm the importer/applicant, whether the route runs through MoIAT or an Emirate/Municipality requirement, label language, and the conformity or registration path. Do not reuse a Saudi dossier as-is.
- If yes, and market = Kuwait, Qatar, Bahrain, Oman: treat each as its own country execution — documents, label language and permitted claims differ.
- If the claim implies a mechanism or a medical benefit (follicle nutrition, hair growth, acne treatment, “clinically proven” cure): stop the ordinary cosmetic route and get market-by-market regulatory classification before you print anything.
- If you only have accelerated data: present shelf life as provisional, keep printing decisions open, and continue real-time long-term study. Do not apply a fixed “1 month at high temperature = X months at ambient” conversion.
- If the pack, the botanical extract supplier, or the process has changed: re-run compatibility, assess stability re-test and PET, and re-evaluate the shelf-life claim.
- Boundary cases needing specialist input: drug/OTC overlap in the destination market (follow pharmaceutical stability rules, not cosmetic logic), aerosols and dangerous goods, fragrance allergen thresholds above labeling limits, and any “worldwide compliant” expectation.
What to ask your manufacturer — the minimum evidence pack
Send this as a single request. A manufacturer who already holds these documents can answer within days; one who does not is telling you something important about the project timeline.
A) Compliance and registration
- Request: written confirmation of the regulatory route per destination country (Saudi, UAE, or others), including who acts as importer/notifier.
Evidence: a country execution sheet naming the framework, the local responsible party and the documents required.
Owner: Manufacturer + Buyer (local importer).
Acceptance criteria: one line per country, no “GCC-wide” or “Middle East certificate” wording.
- Request: classification confirmation that the SKU is an ordinary cosmetic, not a drug or borderline product.
Evidence: claim-by-claim classification note signed by regulatory affairs.
Owner: Manufacturer (regulatory).
Acceptance criteria: every marketing claim mapped to either a cosmetic claim with support or a flagged risk.
- Request: SDS and dangerous-goods documentation prepared for the actual shipping version.
Evidence: current SDS dated within validity, plus transport classification for the fill volume and format.
Owner: Manufacturer.
Acceptance criteria: SDS revision date and formula version match the batch being quoted.
B) Testing and substantiation
- Request: the long-term (real-time, target storage) stability protocol and the raw data at each timepoint.
Evidence: protocol with storage conditions, test items (appearance, odor, pH, viscosity, color, microbial, functional indicators) and timepoint table starting at T0.
Owner: Manufacturer + Lab.
Acceptance criteria: documented protocol and at least T0 plus the latest completed timepoint; no single universal temperature/time combination assumed.
- Request: accelerated study data labeled explicitly as supportive only.
Evidence: report stating purpose (screening/support) and the limitation that it cannot be extrapolated into a shelf-life duration.
Owner: Lab.
Acceptance criteria: no multiplication factor appears anywhere in the report or the sales deck.
- Request: preservative efficacy test and microbiological specification.
Evidence: PET report on the final formula, micro limits, and the sampling plan used in production.
Owner: Lab + Manufacturer (microbiology).
Acceptance criteria: PET performed on the current formula version and container; results within the declared spec.
- Request: packaging compatibility and function data.
Evidence: seal integrity, drop/leak, pump or dropper dose reproducibility, weight-loss/evaporation, and label adhesion reports, plus fragrance–plastic interaction notes.
Owner: Packaging supplier + Manufacturer.
Acceptance criteria: compatibility run on the actual pack components, not a lab surrogate.
C) Labeling and claims guardrails
- Request: the complete label pack with INCI, net content, batch code, production date, expiry date or PAO, and fragrance allergen declaration where required.
Evidence: print-ready artwork plus a label review record against destination-market requirements, including Arabic or bilingual requirements for Saudi.
Owner: Manufacturer (regulatory) + Buyer.
Acceptance criteria: signed-off artwork whose date logic matches the stability conclusion, not the sales target.
- Request: claim substantiation file for anything stronger than moisturizing or appearance language.
Evidence: product-specific study or a documented decision to soften the claim; ingredient studies are not product proof.
Owner: Manufacturer + Buyer.
Acceptance criteria: “clinically proven” appears only with a relevant study on the exact product and benefit.
D) QA, traceability and audit readiness
- Request: batch record template, COA template and retention-sample plan.
Evidence: batch record showing rework/reprocess controls (reason, approval, risk assessment, traceable quantities), COA per batch, and a retention plan with controlled storage and timepoints (for example 0, 3, 6, 12, 18, 24, 36 months).
Owner: Manufacturer (QA).
Acceptance criteria: retention samples drawn from a commercial batch and stored under controlled conditions.
- Request: change-control procedure covering supplier and process changes.
Evidence: a worked example — botanical supplier A to B — showing stability re-test, PET re-assessment, micro spec review and shelf-life impact assessment.
Owner: Manufacturer (QA + R&D).
Acceptance criteria: written trigger list showing which changes restart long-term study.
Evidence pack summary — one line each
- Country execution sheet per destination, naming importer/notifier and required documents.
- Claim classification note confirming ordinary cosmetic status per market.
- Long-term stability protocol with defined storage conditions and timepoints.
- Raw long-term stability data at each completed timepoint.
- Accelerated study report marked “support only, not extrapolable”.
- Preservative efficacy test report on the current formula and pack.
- Microbiological specification and production sampling plan.
- Packaging compatibility report: seal, leak, dose, evaporation, label adhesion.
- Print-ready label artwork with INCI, dates, PAO and allergen declaration.
- COA template and a sample COA from a real batch.
- SDS matching the shipping formula version, plus transport classification.
- Retention sample plan and change-control procedure.
Timeline — two realistic paths
Timings below assume a locked formula and a chosen pack supplier. Everything slips when the pack changes mid-study, because compatibility and stability restart together.
| Phase |
Buyer action |
Manufacturer action |
Evidence output |
Fast path note |
| Specification and market lock |
Confirm country list, importer/notifier, positioning, claims |
Confirm route per country and claim classification |
Country execution sheet + claim note |
Compressible to days if one country only |
| Formula and packaging lock |
Approve formula version and pack components |
Freeze BOM, order compatibility samples |
Frozen spec sheet + BOM |
Never compress — this is the restart point for everything |
| Pilot batch and T0 |
Approve pilot batch |
Run pilot, pull stability, micro and retention samples at T0 |
T0 data set + batch record |
Compressible by parallelizing micro and stability |
| Testing lead time |
Review interim data before committing volume |
Run PET, micro, compatibility; continue long-term study |
PET, micro and compatibility reports |
Not compressible — real time is the evidence |
| Label review |
Approve artwork and date logic |
Regulatory review against destination requirements |
Signed label review record |
Compressible if artwork starts at pilot stage |
| Final documentation handoff |
File the evidence pack before shipment |
Issue COA, SDS, stability summary, retention plan |
Complete shipment dossier |
Never compress — missing SDS or COA stalls clearance |
Fastest safe path: one destination country, existing formula, existing pack, long-term study already at 6–12 months, label reviewed in parallel with the pilot. You compress administration and artwork, never real-time data.
Standard path: new formula or new pack, two or more Gulf markets, claims requiring product-specific support. Start the long-term study at pilot, hold the printed expiry date until the data supports it, and use a conservative initial claim that you can extend later with additional timepoints.
Common failure modes — and what to request so they do not repeat
- Symptom: serum separates or discolors after two months in a Jebel Ali warehouse.
Root cause: stability was judged only on accelerated samples, and the printed expiry assumed a heat-to-ambient conversion.
Prevention: base the date on long-term data; treat accelerated results as screening only.
What to request from factory: long-term protocol and raw data at each timepoint.
- Symptom: pump doses unevenly or the dropper leaks in transit.
Root cause: compatibility tested with a lab bottle, not the production component; viscosity drift changed dose volume.
Prevention: compatibility run on the actual pack, including dose reproducibility at end of shelf life.
What to request from factory: compatibility and function report naming the exact component supplier and mould.
- Symptom: label lifting or ink smearing on filled units.
Root cause: adhesive not validated for the bottle resin and for the oil or fragrance load migrating to the surface.
Prevention: adhesion testing on filled, aged units rather than empty shells.
What to request from factory: label adhesion report on aged filled samples, plus fragrance–plastic interaction notes.
- Symptom: container smells off or the fragrance shifts after three months.
Root cause: fragrance components interacting with the plastic or elastomer, or preservative depletion in the pack.
Prevention: interaction screening before pack approval and micro/PET review at a later timepoint.
What to request from factory: interaction screening report plus stability data on filled packs, not glass surrogates.
- Symptom: customs or the importer asks for a document you do not have.
Root cause: documentation failure — no COA for the shipped batch, SDS for an older formula version, stability summary never issued.
Prevention: define the shipment dossier as a release gate, not an afterthought.
What to request from factory: batch-specific COA, current SDS, stability summary and retention plan before booking freight.
- Symptom: label review rejects the artwork for date or PAO wording.
Root cause: artwork written to a marketing target rather than to the stability conclusion; label language not aligned to the destination market.
Prevention: regulatory review of the date logic and language before print.
What to request from factory: signed label review record tied to the stability report revision.
- Symptom: imported batch is held because INCI on pack does not match the notification file.
Root cause: documentation failure — formula version drift between the filing, the COA and the printed label.
Prevention: one version-control rule linking formula version, COA, SDS, label and filing.
What to request from factory: version-controlled INCI sheet with the effective date of the last change.
- Symptom: a supplier change quietly invalidates the shelf life you already printed.
Root cause: botanical extract or preservative supplier swapped for supply reasons without change control.
Prevention: written change notification clause and a re-test trigger list.
What to request from factory: change-control procedure plus the stability, PET and micro re-assessment plan.
Red lines — what never gets cut to hit a launch date
- Long-term stability data behind the printed expiry date.
- Preservative efficacy test on the current formula and pack.
- Microbiological specification and sampling plan.
- Packaging compatibility and seal integrity on production components.
- Market-correct label content: INCI, dates, PAO, language, allergen declaration.
- COA and SDS matching the shipping version.
Copy-paste checklist and decision summary
Share the destination country list (Saudi, UAE, or others) and the intended importer/notifier.
Confirm each country's route and required documents per market, not as one GCC bundle.
Confirm your SKU is classified as an ordinary cosmetic in each destination.
Provide the long-term stability protocol with storage conditions and timepoint schedule.
Attach raw long-term stability data at every completed timepoint.
Label accelerated data as screening or support only, with no extrapolation factor.
Provide the preservative efficacy test report for the current formula and pack.
Attach the microbiological specification and production sampling plan.
Test the actual pack: seal integrity, leak, dose reproducibility, evaporation.
Review label adhesion and fragrance-plastic interaction on filled, aged units.
Provide print-ready artwork with INCI, batch, production date, expiry or PAO.
Confirm label language and allergen declaration for the destination market.
Attach a claim substantiation file for any efficacy claim beyond appearance.
Lock the formula version and BOM before stability samples are pulled.
Confirm the change-control trigger list for supplier and process changes.
Approve the artwork only after the date logic matches the stability conclusion.
Book the retention sample plan and confirm controlled storage conditions.
Provide a batch-specific COA with the shipment.
Provide an SDS matching the shipping formula version and transport classification.
Review the shipment dossier before freight booking, not after arrival.
Approve volume release only when the evidence pack is complete.
| Lever / Decision |
Primary impact |
What to do (specific) |
Do NOT cut (red line) |
Evidence needed (request) |
Expected timeline effect |
| Country-specific route |
Clearance and label acceptance |
Write one execution line per country naming framework and importer/notifier |
Market-specific document set, not a generic regional certificate |
Country execution sheet |
Prevents rework at shipment stage |
| Claim classification |
Whether the ordinary cosmetic route applies |
Map every claim to cosmetic or flagged risk before artwork |
No treatment or mechanism claims without market review |
Claim classification note |
Avoids late relaunch |
| Shelf-life basis |
Validity of the printed expiry date |
Base the date on long-term data; use accelerated only for screening |
Real-time long-term study at defined timepoints |
Protocol plus raw data |
Adds weeks upfront, avoids recall later |
| Preservative system |
Microbiological safety in a hot, humid market |
Run PET on final formula and pack; review micro spec |
PET on the current formula and container |
PET report and micro specification |
Runs in parallel with stability |
| Pack choice |
Leak, dose and label performance |
Lock components before stability samples are pulled |
Compatibility on production components |
Seal, leak, dose and adhesion reports |
Pack changes restart the clock |
| Label and PAO wording |
Importer and authority acceptance |
Review date logic and language before print |
INCI, dates, PAO, allergen declaration, label language |
Signed label review record |
Early review removes a late blocker |
| Documentation handoff |
Customs and retailer release |
Treat the shipment dossier as a release gate |
Batch COA and SDS matching the shipping version |
COA, SDS, stability summary |
Prevents goods held at port |
| Post-launch verification |
Confidence in the declared shelf life |
Retain samples from a commercial batch in controlled storage |
Retention at 0, 3, 6, 12, 18, 24, 36 months |
Retention plan and review records |
Supports future claim extension |
| Change control |
Protection against silent invalidation |
Require written notification before any supplier or process change |
Stability and PET re-assessment after change |
Change-control procedure |
Avoids unplanned re-testing cycles |
FAQ
Can we print a 36-month expiry based on accelerated data?
No. Accelerated conditions are a screening and support tool. Heating a sample for a few months does not convert into a fixed multiple of ambient shelf life, and there is no universal temperature-and-time combination that applies to every formula. Print what long-term data supports, and extend the claim only as further timepoints complete.
Do we need shelf-life data if the destination market does not mandate an expiry date on the label?
Yes, for commercial reasons even where the label rule is flexible. The manufacturer still owns the responsibility for product safety and for the shelf life it declares, and Gulf importers and retailers routinely ask for it. Contamination from raw materials, water, production conditions, preservative failure or consumer use can all degrade a product, and the importer carries the reputational risk of a rejected pallet.
Is one stability report enough for both Saudi Arabia and the UAE?
The technical data usually transfers; the regulatory wrapper does not. Saudi Arabia involves a local importer/notifier, applicable SFDA/GSO requirements, Arabic or bilingual labeling, INCI, dates/PAO, SDS and customs documents. The UAE runs through MoIAT or an Emirate/Municipality requirement with its own applicant, label language and conformity path. Ask for a separate execution sheet per country.
Our manufacturer changed the botanical extract supplier. Does the shelf life still stand?
Treat it as an open question until assessed. A new botanical source can change chemical composition and microbial load, which affects chemical stability and preservative challenge results. Expect a stability re-test, a preservative efficacy re-assessment, a micro specification review, a packaging impact check and a formal evaluation of whether the long-term study must restart.
What information speeds up a quotation?
Target market or markets, SKU count and formats, positioning, packaging direction (component type and material), and your launch timeline. With those five inputs, a manufacturer can quote realistically instead of quoting a range it cannot commit to.
Next step
If you are preparing a Gulf launch and want the evidence pack scoped against your actual SKUs, formats and destination countries, Request a Quote. Include your target markets, SKU list and formats, positioning, packaging direction and timeline target — that is what turns a quotation into a plan you can hold a supplier to.
LAEYO
Hi, I'm your LAEYO representative, hope you like this blog post.
With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.